Actively Recruiting
Lasertherapy for Vulvodynia
Led by Medical University of Graz · Updated on 2025-03-04
92
Participants Needed
1
Research Sites
288 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study aims to assess the efficacy, acceptance and safety profile of vulvovaginal laser therapy in women with vulvodynia.
CONDITIONS
Official Title
Lasertherapy for Vulvodynia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women with vulvodynia diagnosed according to the 2015 Consensus Terminology
- Multidisciplinary treatment for at least 3 months
- Informed consent provided
You will not qualify if you...
- Current genital infection such as candidiasis or herpes
- Inflammatory vulvar diseases like lichen sclerosus or lichen planus
- Neoplastic vulvar diseases such as HSIL Vulva or Paget disease
- Recent vulvar trauma including bleeding, erosion, or ulceration
- Pudendal neuralgia
- Pregnancy or delivery within the last 6 months
- Epilepsy or major neurological or psychiatric disorders
- Active systemic infection
- Previous ionizing radiation treatment in the target area
- History of wound healing disorders like hyperpigmentation or abnormal scarring
- Fever
- Systemic or local autoimmune disorders
- History of photosensitivity disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Obstetrics and Gynecology/ Medical University of Graz
Graz, Austria, 8036
Actively Recruiting
Research Team
G
Gerda Trutnovsky, MD
CONTACT
K
Karl Tamussino, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here